Chatham House, February 9-10


Monday, November 12, 2007

Biotechnology Conference Schedule: January 2008

Organizer Conference Name Month Start Date End Date Days Location
Pharmapack Pacific Symposium on Biocomputing 2008 January 1/4/2008 1/8/2008 5 Hawaii, USA
GSA Genetic Analysis: Model Organisms to Human Biology 2 January 1/5/2008 TBA TBA San Diego
GRC  Autophagy In Stress, Development and Disease January 1/6/2008 TBA TBA Ventura Beach Marriott
CHI Pep Talk January 1/7/2008 1/11/2008 5 Coronado, CA
Biochemical Society Mechanics & Control of Cytokinesis January 1/9/2008 1/12/2008 4 Edinburgh, UK
WBR Natural Products Conference 2008 January 1/10/2008 1/13/2008 4 Bolans Village, Antigua and Barbuda 
GTCbio Aging & Anti-Aging January 1/10/2008 1/11/2008 2 San Francisco, CA
Kenes International Molecular Basis for Biological Membrane Organization January 1/12/2008 TBA TBA Big Sky, Montana
GRC  Biomolecular Interactions & Methods January 1/13/2008 TBA TBA Four Points Sheraton
GRC  Composites January 1/13/2008 TBA TBA Crowne Plaza
CHI High Content Analysis January 1/14/2008 1/17/2008 4 San Francisco, CA
GTCbio Oncology Biomarkers January 1/14/2008 1/15/2008 2 San Francisco, CA
ACR Radiation Therapy Oncology Group January 1/17/2008 1/20/2008 4 San Diego, CA
Terrapinn Ltd. 2nd Annual Medical Science Liaison Skill Set Training January 1/17/2008 TBA TBA Philadelphia, PA
Zing Drug Discovery Conference January 1/17/2008 TBA TBA Bolans Village, Antigua and Barbuda 
Biochemical Society RNK UK 2008 January 1/18/2008 1/20/2008 3 Windermere, UK
SORIS BIOS 2008 January 1/19/2008 1/24/2008 6 San Jose, CA
Saudi Society of Nephrology SBE's 1st International Conference on Stem Cell Engineering January 1/20/2008 1/23/2008 4 Coronado, CA
IGBF The 12th Annual Drug Delivery Partnerships January 1/21/2008 TBA TBA San Diego, CA
Messe Dusseldorf Asia Predictive Human Toxicity & ADME/Tox Studies January 1/22/2008 1/25/2008 4 Zurich, Switzerland
ACI 2nd Imaging in Clinical Trials January 1/23/2008 TBA TBA London, UK
IIR 6th Annual Partnering with Central Labs, ECG and Imaging Core Labs January 1/23/2008 TBA TBA Lake Buena Vista, FL
The Center for Business Intelligence 5th Annual Specialty Pharmaceuticals, Biotech Therapies & Injectables January 1/24/2008 TBA TBA Las Vegas, NV
The Center for Business Intelligence 7th Annual Pharmaceutical Contact Centers January 1/24/2008 TBA TBA TBD
ASCO 2008 Gastrointestinal Cancers Symposium January 1/25/2008 1/27/2008 3 Orlando, FL
SIR Nuclear Medicine: 2008 PET & PET/CT January 1/27/2008 1/31/2008 5 St. Kitts
BIO Asia Partnering Conference 2008 January 1/28/2008 1/29/2008 2 Tokyo, Japan
BIO BIO-Asia January 1/28/2008 1/29/2008 2 Tokyo, Japan
Biostec International Joint Conference on Biomedical Engineering Systems and Technologies January 1/28/2008 1/31/2008 4 Portugal
Euroscicon Molecular Farming - plant biologicals  January 1/28/2008 1/28/2008 1 Welwyn Garden City, UK
Keystone Symposia Translational Regulatory Mechanisms January 1/28/2008 2/2/2008 6 Idaho, USA
PDA Phacilitate Vaccine Forum Washington 2008 January 1/28/2008 TBA TBA  Washington DC
Phacilitate Phacilitate Cell & Gene Therapy Forum 2008 January 1/28/2008 TBA TBA Washington DC
The Center for Business Intelligence 5th Annal Pharmaceutical Marketing Compliance Congress January 1/28/2008 TBA TBA Washington, DC
GTCbio Cytokines & Inflammation (5th Annual) January 1/28/2008 1/29/2008 2 Orlando, Florida
CMP ICSE USA January 1/29/2008 2/1/2008 4 New Orleans, US
CMP InformEx USA  2008 January 1/29/2008 2/1/2008 4 New Orleans, LA
ACCME 27th Annual Advanced Nephrology: Nephrology for the Consultant January 1/31/2008 2/2/2008 3 San Diego, CA

5 comments:

DNAmite said...

GTCbio's New Applications in Aging Research - http://gtcbio.com/userAgenda.aspx?id=113
was a major success. All the big names in aging research including Michael West, Leonard Guarente, Michael Rose and others were there.

Also a new company called Genescient was first featured at the meeting. Elixir, Sirtris and many other companies pale when compared to Genescient in terms of market potential...

I highly recommend this conference to everyone.

DNAmite said...

Another great meeting I attended was Oncology Biomarkers in San Francisco.
Very high level speakers, excellent attendance.

The meeting inspired me to start www.OncologyBiomarkers.com blog and to start working on a Biomarker Research market report.

DNAmite said...

Biogerontology Research Foundation receives charitable status from the Charity Commission

On Wednesday, May 14 Biogerontology Research Foundation (BGRF) has met the requirements of the Charity Commission for England and Wales and received a charitable status with the registration number 1124054.
Source: Biogerontology Research Foundation
Jun 11, 2008 08:22:53 Click to see PDF Version of this Press Release


FOR IMMEDIATE RELEASE
PRLog (Press Release) – Jun 11, 2008 – Reading, UK - On Wednesday, May 14 Biogerontology Research Foundation (BGRF) has met the requirements of the Charity Commission for England and Wales and received a charitable status with the registration number 1124054.

The mission of the BGRF is to support the application of our knowledge of the mechanisms of ageing to the relief of disability, suffering and disease in old age. The formal aims of the charity are to relieve sickness and preserve, protect and advance all or any aspects of the health of elderly persons and to advance the education of the public in the field of biogerontology

”The decision to grant the BGRF registration as a UK charity represents an important milestone in the effort to defeat the diseases of aging. It will provide us with a platform to direct resources towards drastically underfunded scientific research projects that target the causes of age-related disease, rather than just the symptoms. We are looking forward to engaging with the wider community for support in the pursuit of this important mission”, said Damian Crowe, Managing Trustee of the BGRF.

The BGRF will actively pursue and encourage projects identified by its scientific team as key to these goals. The science of the projects will be screened by a Scientific Advisory Board consisting of world-class researchers in biogerontology and related fields, in consultation with external experts as appropriate. Although these projects may be long term in nature, they will be designed to generate interim results and products that create academic and commercial interest, thereby bringing further resources into play and accelerating progress. As a key component of this strategy, The BGRF will seek appropriate Intellectual Property protection to encourage industry to apply the results of our projects quickly. Our long-term goal is to provide medical practitioners with the tools they need to enable effective and lasting remedies for the illnesses and disabilities of old age.

"The BGRF will fill an critical gap in the funding spectrum between basic research and its application to alleviate disease in old age. Our establishment as a registered charity is an important step in realising our research and its application to treating the casuses of those diseases", said William Bains, PhD, Trustee of the BGRF.

Donations to the BGRF are welcome. For more information on how to donate to the BGRF or provide qualified services on a volunteer basis, please contact Alex Zhavoronkov, PhD at alex.zhavoronkov@bg-rf.org.uk .

Details on the Charities Commission for England and Wales registration are available at charity-commission.gov.uk/registeredcharities/showcharity.asp?remchar=&chyno=dav1124054 .


About the Biogerontology Research Foundation:
The Biogerontology Research Foundation seeks to fill a gap within the research community, whereby the current scientific understanding of the ageing process is not yet being sufficiently exploited to produce effective medical interventions. The BGRF will fund research which, building on the body of knowledge about how ageing happens, will develop biotechnological interventions to remediate the molecular and cellular deficits which accumulate with age and which underlie the ill-health of old age. Addressing ageing damage at this most fundamental level will provide an important opportunity to produce the effective, lasting treatments for the diseases and disabilities of ageing, which are required to improve quality of life in the elderly. The BGRF seeks to use the entire scope of modern biotechnology to attack the changes that take place in the course of aging, and to address not just the symptoms of age-related diseases but also the mechanisms of those diseases.

About the Charity Commission for England and Wales
The Charity Commission for England and Wales is established by law as the regulator and registrar of charities in England and Wales. The aim of the Charity Commission is to provide the best possible regulation of these charities in order to increase charities’ efficiency and effectiveness and public confidence and trust in them.
The Charity Commission for England and Wales publication The Charity Commission and Regulation describes in more detail Commission’s values and operation as a regulator.


Contact:
Biogerontology Research Foundation
Kings Lodge
194 Kings Rd.
Reading, Berkshire
RG1 4NH, UK
www.bg-rf.org.uk
Alex Zhavoronkov, PhD
+44 20 8144 7774
alex.zhavoronkov@bg-fr.org.uk

DNAmite said...

At the Aging Research conference I also learned about an interesting concept of using isotope-stabilized compounds to combat ROS-associated damage. You can read about it at www.agingcell.com

Matrikiran said...

I like very much your way of presentation Some great information to be absorbed in this post.Thanks a lot for sharing.
Education by Vatika | real estate in gurgaon | vatika floors gurgaon | Web Design Company